메뉴 건너뛰기




Volumn 35, Issue 3, 2012, Pages 319-326

PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation

Author keywords

BT 549 cells; Paclitaxel; Pharmacokinetics; PLGA 50:50

Indexed keywords

ANTI-TUMOR ACTIVITIES; BREAST CANCER TREATMENT; BURST RELEASE; CELL LINES; CLEARANCE RATES; DRUG DELIVERY SYSTEM; EMULSION SOLVENT EVAPORATION; ENCAPSULATION EFFICIENCY; HYDROPHOBIC DRUG; IN-VITRO; IN-VIVO; PACLITAXEL; PHARMACOKINETIC PROFILES; PHYSICOCHEMICAL PARAMETERS; PLGA 50:50; PLGA NANOPARTICLES;

EID: 84863495964     PISSN: 02504707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12034-012-0313-7     Document Type: Article
Times cited : (81)

References (22)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.